Celltrion
068270.KS
#712
Rank
NZ$49.64 B
Marketcap
$241.55
Share price
3.11%
Change (1 day)
8.05%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2024 (TTM): NZ$0.74 Billion

According to Celltrion 's latest financial reports the company's current earnings are NZ$2.15 Billion. In 2023 the company made an earning of NZ$0.89 Billion, an increase over its 2022 earnings that were of NZ$0.83 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.74 B-16.93%
2023 NZ$0.89 B6.8%
2022 NZ$0.83 B-21.85%
2021 NZ$1.07 B10.25%
2020 NZ$0.97 B65.16%
2019 NZ$0.58 B16.64%
2018 NZ$0.50 B-33.89%
2017 NZ$0.76 B106.53%
2016 NZ$0.36 B25.57%
2015 NZ$0.29 B-6.54%
2014 NZ$0.31 B47.36%
2013 NZ$0.21 B-33.63%
2012 NZ$0.32 B
2010 NZ$0.16 B72.84%
2009 NZ$96.65 M260.54%
2008 NZ$26.8 M